Satsuma Pharmaceuticals Inc (STSA) is down 0.93% Friday In Premarket Trading

Friday, May 19, 2023 09:18 AM | InvestorsObserver Analysts

Mentioned in this article

Satsuma Pharmaceuticals Inc (STSA) is down 0.93% Friday In Premarket Trading

Satsuma Pharmaceuticals Inc (STSA) has fallen Friday morning, with the stock decreasing -0.93% in pre-market trading to 1.06. STSA's short-term technical score of 72 indicates that the stock has traded more bullishly over the last month than 72% of stocks on the market. In the Biotechnology industry, which ranks 87 out of 146 industries, STSA ranks higher than 74% of stocks. Satsuma Pharmaceuticals Inc has risen 5.94% over the past month, closing at $1.04 on April 21. During this period of time, the stock fell as low as $1.03 and as high as $1.09. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

STSA has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 81. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 19% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, STSA ranks better than 89% of stocks.

Important Dates for Investors in STSA:

-Satsuma Pharmaceuticals Inc is set to release earnings on 8/9/2023. Over the last 12 months, the company has reported EPS of $-0.31. -We do not have a set dividend date for Satsuma Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Satsuma Pharmaceuticals Inc (STSA)